Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Total Current Liabilities (2016 - 2026)

Tenax Therapeutics' Total Current Liabilities history spans 6 years, with the latest figure at $1.0 million for Q4 2017.

  • On a quarterly basis, Total Current Liabilities fell 83.73% to $1.0 million in Q4 2017 year-over-year; TTM through Dec 2017 was $1.0 million, a 83.73% decrease, with the full-year FY2017 number at $1.0 million, down 83.73% from a year prior.
  • Total Current Liabilities hit $1.0 million in Q4 2017 for Tenax Therapeutics, up from $838552.0 in the prior quarter.
  • Over the last five years, Total Current Liabilities for TENX hit a ceiling of $6.2 million in Q4 2016 and a floor of $838552.0 in Q3 2017.
  • Historically, Total Current Liabilities has averaged $3.4 million across 4 years, with a median of $3.4 million in 2015.
  • Biggest five-year swings in Total Current Liabilities: soared 34.72% in 2016 and later tumbled 83.73% in 2017.
  • Tracing TENX's Total Current Liabilities over 4 years: stood at $1.9 million in 2013, then soared by 140.98% to $4.6 million in 2015, then soared by 34.72% to $6.2 million in 2016, then tumbled by 83.73% to $1.0 million in 2017.
  • Business Quant data shows Total Current Liabilities for TENX at $1.0 million in Q4 2017, $838552.0 in Q3 2017, and $2.2 million in Q2 2017.